Reaction
Chronic Graft Versus Host Disease In Eye reporting signals
As of the last recalculation, Chronic Graft Versus Host Disease In Eye appears in 195 FAERS reports alongside 11 co-occurring drug terms. The strongest observed disproportionality signal is BUSULFAN (PRR 221.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Busulfan | 28 | 221.6 | 222.0 |
| Fludarabine Phosphate | 53 | 197.2 | 197.5 |
| Sirolimus | 20 | 176.4 | 176.7 |
| Tacrolimus Ointment 0.1% | 84 | 125.7 | 125.8 |
| Tacrolimus Extended-Release Capsules | 84 | 125.4 | 125.5 |
| Posaconazole Delayed-Release | 11 | 113.2 | 113.4 |
| Blinatumomab | 9 | 96.5 | 96.6 |
| Thiotepa | 8 | 93.2 | 93.3 |
| Posaconazole | 11 | 76.5 | 76.6 |
| Ruxolitinib | 40 | 74.7 | 74.7 |
| Azacitidine | 9 | 33.9 | 33.9 |